World Health Organization Raises Warning Over Critical Shortage of Obesity Jabs

Less than one in 10 individuals eligible to benefit from obesity jabs like Wegovy are able to get them, caution the WHO as it issues its initial recommendations on the medications.

With in excess of 1,000,000,000 individuals worldwide now living with obesity, it is calling for more widespread and fairer availability to these injectable treatments.

According to estimates, in excess of 2,000,000,000 could be living with obesity by 2030 unless action is taken.

"The latest guidance affirms that excess weight is a lifelong illness that can be addressed with thorough and lifelong care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are significant barriers to widespread access to the injections that can help people shift considerable body mass, says the body.

GLP-1 Therapy Supply Crisis

Even in the current most favorable outlook, the manufacturing of these medications would only suffice for around 100 million people – fewer than 10% of the global need, per the health organization.

The advice calls on nations and manufacturers to widen access, via strategies such as licensing agreements.

A patent on semaglutide – the core component of a leading brand – is set to lapse in a number of nations in 2026.

How Weight-Loss Injections Work

These medications mimick a biological compound to slow digestion, reduce hunger and boost the sense of being full so individuals reduce food intake.

People typically begin shedding pounds within a few weeks of beginning the weekly injections.

Evidence points to users may regain a significant portion a year later of discontinuing the medication, as their normal appetite resume.

To be above a healthy weight elevates your likelihood for developing health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and specific malignancies.

Excess weight affects individuals in all nations and was responsible for millions of fatalities worldwide in 2024, per the WHO.

Susan Ortiz
Susan Ortiz

Lena is a certified financial advisor with over a decade of experience helping individuals achieve financial independence.

Popular Post